ATRS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Stats
Today's Volume	1.76M
Average Volume	5.23M
Market Cap	0.00
EPS	$-0.0136 ( Q1 \| 2022-05-10 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	14.95 (Sector) 42.63 (Industry) 0
ATR14	$0.104 (1.86%)

AKYA -5.56%

ANGO -5.45%

APR 0.00%

ATRC -1.19%

ATRI -0.07%

ATRS 0.18%

AVGR -9.14%

AZTA -3.00%

BLFS -2.99%

EKSO -1.42%

FEMY 2.63%

GMVD 1.38%

HBIO -2.46%

HOLX -0.20%

ICUI -3.26%

IIN 0.12%

ISRG -1.94%

KRMD -11.32%

LMAT -2.09%

LMNX 0.00%

MASI -7.58%

MBOT -0.98%

MHUA 16.15%

MMSI -0.36%

NEPH 0.00%

NSTG -37.43%

NVCR 1.28%

NXGL -0.93%

OSUR 0.23%

PDEX -6.57%

PLSE -3.22%

POAI -0.96%

QDEL -4.79%

RGEN -2.17%

SDC -53.45%

SMTI -4.50%

STAA -0.40%

STSS -2.38%

UTMD -0.33%

XRAY -1.12%

ZTEK 2.94%

Insider Trading

Date	Person	Action	Amount	type
2022-05-24	Gueth Anton	Sell	79 645	Common Stock
2022-05-24	Gueth Anton	Sell	61 930	Stock Option (right to buy)
2022-05-24	Gueth Anton	Sell	99 395	Stock Option (right to buy)
2022-05-24	Gueth Anton	Sell	150 000	Stock Option (right to buy)
2022-05-24	Gueth Anton	Sell	80 318	Stock Option (right to buy)

INSIDER POWER
0.00
Last 97 transactions
Buy: 1 667 582 \| Sell: 3 999 780

Volume Correlation

Long: 0.33 (neutral)

Short: 0.37 (neutral)

Signal:(78.671) Neutral

Antares Pharma Inc Correlation

10 Most Positive Correlations
GTYH	0.833

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Antares Pharma Inc Correlation - Currency/Commodity

-0.55
( weak negative )

-0.54
( weak negative )

-0.76
( moderate negative )

0.24
( neutral )

0.72
( moderate )

-0.20
( neutral )

Antares Pharma Inc Financials

Annual	2021
Revenue:	$183.98M
Gross Profit:	$115.70M (62.89 %)
EPS:	$0.280

FY	2021
Revenue:	$183.98M
Gross Profit:	$115.70M (62.89 %)
EPS:	$0.280

FY	2020
Revenue:	$149.60M
Gross Profit:	$86.50M (57.82 %)
EPS:	$0.340

FY	2019
Revenue:	$123.86M
Gross Profit:	$73.39M (59.25 %)
EPS:	$-0.0100

Financial Reports:

No articles found.

Antares Pharma Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Antares Pharma Inc

Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. It develops, manufactures, and commercializes novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto-injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto-injectors; TLANDO to treat deficiency or absence of endogenous testosterone in adult males; and drug/device products for urologic oncology, immunology, and endocrinology. The company has strategic alliances and partnerships with Pfizer Inc., Idorsia Pharmaceuticals Ltd, Teva Pharmaceutical Industries, Ltd, and AMAG. Antares Pharma, Inc. was incorporated in 1979 and is headquartered in Ewing, New Jersey. As of May 23, 2022, Antares Pharma, Inc. operates as a subsidiary of Halozyme Therapeutics, Inc.